Joint Formulary & PAD

C1-Esterase inhibitor - Hereditary angiodema - EMERGENCY treatment

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
C1-Esterase inhibitor
Indication :
Hereditary angiodema - EMERGENCY treatment
Group Name :
Keywords :
acute hereditary angiodema
Brand Names Include :
Berinert, Cetor, Cinryze
Important Information :
Prevention / prophylaxis is commissioned by NHSE. RSFT are the only Surrey Trust to which this applies.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that C1-Esterase inhibitor is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hereditary angiodema - EMERGENCY treatment.

  • No records returned.